SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-043454
Filing Date
2021-08-11
Accepted
2021-08-11 16:21:18
Documents
73
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rxdx-10q_20210630.htm   iXBRL 10-Q 2310870
2 EX-10.1 rxdx-ex101_241.htm EX-10.1 210165
3 EX-31.1 rxdx-ex311_7.htm EX-31.1 20633
4 EX-31.2 rxdx-ex312_8.htm EX-31.2 20607
5 EX-32.1 rxdx-ex321_6.htm EX-32.1 10025
6 EX-32.2 rxdx-ex322_10.htm EX-32.2 10053
  Complete submission text file 0001564590-21-043454.txt   8892337

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA rxdx-20210630.xsd EX-101.SCH 73011
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxdx-20210630_cal.xml EX-101.CAL 50746
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxdx-20210630_def.xml EX-101.DEF 275629
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxdx-20210630_lab.xml EX-101.LAB 529707
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxdx-20210630_pre.xml EX-101.PRE 420983
12 EXTRACTED XBRL INSTANCE DOCUMENT rxdx-10q_20210630_htm.xml XML 1369429
Mailing Address 9410 CARROLL PARK DRIVE SAN DIEGO CA 92121
Business Address 9410 CARROLL PARK DRIVE SAN DIEGO CA 92121 (858) 200-7888
Prometheus Biosciences, Inc. (Filer) CIK: 0001718852 (see all company filings)

IRS No.: 814282653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40187 | Film No.: 211163709
SIC: 2834 Pharmaceutical Preparations